UnknownNCT04926142
Prevalence of Atrial Fibrillation in Cryptogenic Stroke With Patent Foramen Ovale Closure (PFO-AF) Study
Studying Hereditary atrial fibrillation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Principal Investigator
- Marc Badoz, MDCentre Hospitalier Universitaire de Besancon
- Intervention
- Implantation of Holter device(device)
- Enrollment
- 250 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2025
Study locations (4)
- University Hospital Besancon, Besançon, France
- CHU Lyon - Hôpital Louis Pradel, Bron, France
- CHU Dijon, Dijon, France
- CHU Grenoble, Grenoble, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04926142 on ClinicalTrials.govOther trials for Hereditary atrial fibrillation
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06578104PULSED AF Post-Approval StudyMedtronic Cardiac Ablation Solutions
- RECRUITINGNANCT05951101Zenith LAA Occlusion SystemAuriGen Medical Ltd
- RECRUITINGNCT05190679Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial FibrillationVanderbilt University Medical Center
- RECRUITINGPHASE3NCT04045665Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGIcahn School of Medicine at Mount Sinai